256 related articles for article (PubMed ID: 30134855)
1. A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report.
Zhou N; Schäfer R; Li T; Fang M; Liu L
BMC Cancer; 2018 Aug; 18(1):842. PubMed ID: 30134855
[TBL] [Abstract][Full Text] [Related]
2. Refractory and metastatic infantile fibrosarcoma harboring
Bender J; Anderson B; Bloom DA; Rabah R; McDougall R; Vats P; Mody R
Cold Spring Harb Mol Case Stud; 2019 Feb; 5(1):. PubMed ID: 30709876
[TBL] [Abstract][Full Text] [Related]
3. NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.
Park DY; Choi C; Shin E; Lee JH; Kwon CH; Jo HJ; Kim HR; Kim HS; Oh N; Lee JS; Park OK; Park E; Park J; Shin JY; Kim JI; Seo JS; Park HD; Park J
Oncotarget; 2016 Feb; 7(7):8399-412. PubMed ID: 26716414
[TBL] [Abstract][Full Text] [Related]
4. Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment.
Chen W; Wang H; Jiang D; Luan L; Zhou Y; Hou Y
World J Surg Oncol; 2021 Apr; 19(1):136. PubMed ID: 33941195
[TBL] [Abstract][Full Text] [Related]
5. Myxoid Spindle Cell Sarcoma With
So YK; Chow C; To KF; Chan JKC; Cheuk W
Int J Surg Pathol; 2020 Aug; 28(5):574-578. PubMed ID: 32050835
[TBL] [Abstract][Full Text] [Related]
6. Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern.
Haller F; Knopf J; Ackermann A; Bieg M; Kleinheinz K; Schlesner M; Moskalev EA; Will R; Satir AA; Abdelmagid IE; Giedl J; Carbon R; Rompel O; Hartmann A; Wiemann S; Metzler M; Agaimy A
J Pathol; 2016 Apr; 238(5):700-10. PubMed ID: 26863915
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH
Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib.
Wong V; Pavlick D; Brennan T; Yelensky R; Crawford J; Ross JS; Miller VA; Malicki D; Stephens PJ; Ali SM; Ahn H
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563356
[No Abstract] [Full Text] [Related]
9. Larotrectinib followed by selitrectinib in a novel
Goh XN; Seng MS; Loh AHP; Gupta A; Chang KTE; Iyer P
J Oncol Pharm Pract; 2021 Mar; 27(2):485-489. PubMed ID: 32693686
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.
Keung EZ; Lazar AJ; Torres KE; Wang WL; Cormier JN; Ashleigh Guadagnolo B; Bishop AJ; Lin H; Hunt KK; Bird J; Lewis VO; Patel SR; Wargo JA; Somaiah N; Roland CL
BMC Cancer; 2018 Sep; 18(1):913. PubMed ID: 30249211
[TBL] [Abstract][Full Text] [Related]
11. A Case of Inv(1)(q23q31)
Rekhi B; Shetty O; Bapat P; Gurav M; Qureshi S
Int J Surg Pathol; 2021 Feb; 29(1):102-108. PubMed ID: 32489127
[TBL] [Abstract][Full Text] [Related]
12. An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101.
Doebele RC; Davis LE; Vaishnavi A; Le AT; Estrada-Bernal A; Keysar S; Jimeno A; Varella-Garcia M; Aisner DL; Li Y; Stephens PJ; Morosini D; Tuch BB; Fernandes M; Nanda N; Low JA
Cancer Discov; 2015 Oct; 5(10):1049-57. PubMed ID: 26216294
[TBL] [Abstract][Full Text] [Related]
13. Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivo LMNA::NTRK1-rearranged soft-tissue sarcoma cell model.
Chen Y; Steiner S; Hagedorn C; Kollar S; Pliego-Mendieta A; Haberecker M; Plock J; Britschgi C; Planas-Paz L; Pauli C
J Pathol; 2024 Jun; 263(2):257-269. PubMed ID: 38613194
[TBL] [Abstract][Full Text] [Related]
14. The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.
DuBois SG; Laetsch TW; Federman N; Turpin BK; Albert CM; Nagasubramanian R; Anderson ME; Davis JL; Qamoos HE; Reynolds ME; Cruickshank S; Cox MC; Hawkins DS; Mascarenhas L; Pappo AS
Cancer; 2018 Nov; 124(21):4241-4247. PubMed ID: 30204247
[TBL] [Abstract][Full Text] [Related]
15. A novel TMTC2-NTRK3 fusion in undifferentiated high-grade pleomorphic sarcoma.
Bai C; Zhang L; Wang Y; You X; Ju Y; Sun T; Fan Z
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2933-2937. PubMed ID: 35933643
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation Sequencing.
Zheng B; Qu Y; Wang J; Shi Y; Yan W
Cancer Genomics Proteomics; 2019; 16(3):221-228. PubMed ID: 31018952
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Pediatric Soft Tissue Sarcoma with LMNA-NTRK1 Gene Fusion Treated with Larotrectinib under Single Patient Expanded Access System].
Kato S; Fujimura J; Nozaki Y; Yamaguchi S; Takagi T; Hayashi T; Saito T; Henry D; Ku N; Suehara Y
Gan To Kagaku Ryoho; 2019 Oct; 46(10):1595-1597. PubMed ID: 31631147
[TBL] [Abstract][Full Text] [Related]
18. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Cotzia P; Fletcher CDM; Antonescu CR
Genes Chromosomes Cancer; 2018 Dec; 57(12):611-621. PubMed ID: 30276917
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic characterization reveals linear tumor evolution in a pulmonary sarcomatoid carcinomas patient with a novel PHF20-NTRK1 fusion: a case report.
Ge J; Yao B; Huang J; Wu X; Bao H; Ou Q; Shao YW; Chen J
BMC Cancer; 2019 Jun; 19(1):592. PubMed ID: 31208361
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
Sartore-Bianchi A; Ardini E; Bosotti R; Amatu A; Valtorta E; Somaschini A; Raddrizzani L; Palmeri L; Banfi P; Bonazzina E; Misale S; Marrapese G; Leone A; Alzani R; Luo D; Hornby Z; Lim J; Veronese S; Vanzulli A; Bardelli A; Martignoni M; Davite C; Galvani A; Isacchi A; Siena S
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
